{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:02:21Z","timestamp":1791352941192,"version":"4.3.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12,1]]},"DOI":"10.1097\/qai.0b013e31818cdef5","type":"journal-article","created":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T08:11:21Z","timestamp":1226563881000},"page":"384-392","source":"Crossref","is-referenced-by-count":64,"title":["Differences in Factors Associated With Initial Growth, CD4, and Viral Load Responses to ART in HIV-Infected Children in Kampala, Uganda, and the United Kingdom\/Ireland"],"prefix":"10.1097","volume":"49","author":[{"given":"Addy","family":"Kekitiinwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Maganda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Doerholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina B","family":"Kitaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Asiimwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Judd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Musoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/146532807X170448","article-title":"Antiretroviral therapy for children: challenges and opportunities.","volume":"27","author":"Eley","year":"2007","journal-title":"Ann Trop Paediatr"},{"key":"R3-6-20210131","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0140-6736(07)61051-4","article-title":"International perspectives, progress, and future challenges of paediatric HIV infection.","volume":"370","author":"Prendergast","year":"2007","journal-title":"Lancet"},{"key":"R4-6-20210131","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00002030-200202150-00007","article-title":"The extent of HIV-1-related immunodeficiency and age predict the long term CD4 T-lymphocyte response to potent anti-retroviral therapy.","volume":"16","author":"Kaufmann","year":"2002","journal-title":"AIDS"},{"key":"R5-6-20210131","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/00002030-200409240-00007","article-title":"Paediatric Study (CHIPS) Steering Committee. Response to highly active antiretroviral therapy varies with age: the UK and Ireland collaborative HIV paediatric study.","volume":"18","author":"Walker","year":"2004","journal-title":"AIDS"},{"key":"R6-6-20210131","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.298.16.1888","article-title":"Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.","volume":"298","author":"Bolton-Moore","year":"2007","journal-title":"J Am Med Assoc"},{"key":"R7-6-20210131","first-page":"988","article-title":"Antiretroviral treatment for children.","volume":"96","author":"Eley","year":"2006","journal-title":"S Afr Med J"},{"key":"R8-6-20210131","first-page":"1248","article-title":"Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings.","volume":"44","author":"OBrien","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R9-6-20210131","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1097\/INF.0b013e318125720a","article-title":"Sustained immunologic and virologic efficacy after 4 years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand.","volume":"26","author":"Puthanakit","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R10-6-20210131","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/01.inf.0000157095.75081.43","article-title":"Clinical Trials Group 377 Study Team. Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.","volume":"24","author":"Nachman","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R11-6-20210131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/QAI.0b013e31814278c0","article-title":"Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy.","volume":"46","author":"Kamya","year":"2007","journal-title":"J Acquir Immun Defic Syndr"},{"key":"R12-6-20210131","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1542\/peds.109.2.e25","article-title":"Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.","volume":"109","author":"Verweel","year":"2002","journal-title":"Pediatrics"},{"key":"R13-6-20210131","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1542\/peds.111.1.e52","article-title":"Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.","volume":"111","author":"Newell","year":"2003","journal-title":"Pediatrics"},{"key":"R14-6-20210131","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/QAD.0b013e3280e087e7","article-title":"Walker AS, et al, and Paediatric European Network for Treatment of AIDS (PENTA). Lamivudine\/abacavir maintains virological superiority over zidovudine\/lamivudine and zidovudine\/abacavir beyond 5 years in children.","volume":"21","author":"Green","year":"2007","journal-title":"AIDS"},{"key":"R15-6-20210131","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.327.7422.1019","article-title":"Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland.","volume":"327","author":"Gibb","year":"2003","journal-title":"BMJ"},{"key":"R16-6-20210131","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1086\/521167","article-title":"Paediatric Study (CHIPS) Steering Committee. Morbidity, mortality, and response to treatment of perinatally HIV-infected children in the UK and Ireland, 1996-2006: planning for teenage and adult care.","volume":"45","author":"Judd","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"R17-6-20210131","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-1293.2004.00227.x","article-title":"PENTA guidelines for the use of antiretroviral therapy, 2004.","volume":"5","author":"Sharland","year":"2004","journal-title":"HIV Med"},{"key":"R19-6-20210131","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1097-0258(19980228)17:4<407::AID-SIM742>3.0.CO;2-L","article-title":"British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood.","volume":"17","author":"Cole","year":"1998","journal-title":"Stat Med"},{"key":"R20-6-20210131","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/sim.4780131007","article-title":"Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions.","volume":"13","author":"Hess","year":"1994","journal-title":"Stat Med"},{"key":"R21-6-20210131","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R","article-title":"Multiple imputation of missing blood pressure covariates in survival analysis.","volume":"18","author":"van Buuren","year":"1999","journal-title":"Stat Med"},{"key":"R22-6-20210131","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1536867X0400400301","article-title":"Multiple imputation of missing data.","volume":"4","author":"Royston","year":"2004","journal-title":"Stata J"},{"key":"R23-6-20210131","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1086\/500842","article-title":"CD4 response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?","volume":"193","author":"Newell","year":"2006","journal-title":"J Infect Dis"},{"issue":"3","key":"R24-6-20210131","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1086\/338567","article-title":"Immunoreconstitution in children receiving highly active antiretroviral therapy depends on the CD4 call percentage at baseline.","volume":"185","author":"Nikolic-Djokic","year":"2002","journal-title":"J Infect Dis"},{"key":"R25-6-20210131","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/500412","article-title":"Infection. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type-1 infected children: 6 years of follow-up.","volume":"42","author":"Resino","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R26-6-20210131","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(03)15098-2","article-title":"Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1 infected children and adolescents.","volume":"362","author":"Soh","year":"2003","journal-title":"Lancet"},{"key":"R27-6-20210131","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1097\/00002030-200111230-00008","article-title":"Scherpbier HJ, van Lochem EG, et al, and Dutch Study Group for Children with HIV Infections. Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status.","volume":"15","author":"van Rossum","year":"2001","journal-title":"AIDS"},{"key":"R28-6-20210131","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":"Dabis F, et al, and Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration, ART Cohort Collaboration (ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"key":"R29-6-20210131","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/514823","article-title":"Antiretroviral therapy for HIV-1-infected children in Haiti.","volume":"195","author":"George","year":"2007","journal-title":"J Infect Dis"},{"issue":"5","key":"R30-6-20210131","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.qai.0000226334.34717.dc","article-title":"Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP trial.","volume":"42","author":"Walker","year":"2006","journal-title":"J Acquir Immun Defic Syndr"},{"key":"R31-6-20210131","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/apc.2007.0049","article-title":"Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda.","volume":"22","author":"Kabue","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"R32-6-20210131","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1097\/00002030-200311070-00007","article-title":"A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV.","volume":"17","author":"Benjamin","year":"2003","journal-title":"AIDS"},{"key":"R33-6-20210131","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(02)07874-1","article-title":"Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial.","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"R35-6-20210131","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(06)69117-4","article-title":"Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study.","volume":"368","author":"Badri","year":"2006","journal-title":"Lancet"},{"key":"R36-6-20210131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.aids.0000302262.51286.a5","article-title":"3Cs4kids) Analysis and Writing Committee. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis.","volume":"22","year":"2008","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e31818cdef5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:48:52Z","timestamp":1620971332000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200812010-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,1]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31818cdef5","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12,1]]}}}